Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Paul Callaghan
Person

Paul Callaghan

Tracked across 1 events · 7 articles · First seen Aug 05, 2026 · Last active Aug 07, 2026

Sentiment
50
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 50
Business
Mironid raises $46M Series B
Mironid, a Glasgow-based biopharmaceutical company developing small molecule therapeutics for Autosomal Dominant Polycystic Kidney Disease (ADPKD), announced on August 5, 2026 that it raised $46 million in a Series B funding round. The round was…
Impact: Paul Callaghan, Investment Director at SNIB, championed the investment, reflecting positively on his role and SNIB's strategy.
Aug 05, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Paul Callaghan live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.